肝病

隐匿性肝性脑病与不良预后和住院风险相关

作者:佚名 来源:爱唯医学网 日期:2017-07-10
导读

          本研究对比了伴有显性肝性脑病的肝硬化患者和隐蔽性肝性脑病(亚临床型肝性脑病)的肝硬化患者的临床结局。结果发现,伴有隐蔽性肝性脑病的肝硬化患者在随后的1年中往往需要住院治疗并进展为显性肝性脑病。

关键字:  隐匿性肝性脑病 

        本研究对比了伴有显性肝性脑病的肝硬化患者和隐蔽性肝性脑病(亚临床型肝性脑病)的肝硬化患者的临床结局。结果发现,伴有隐蔽性肝性脑病的肝硬化患者在随后的1年中往往需要住院治疗并进展为显性肝性脑病。

        与不伴有隐匿性肝性脑病的肝硬化患者相比,伴有亚临床型肝性脑病的肝硬化患者在进展为显性肝性脑病、需要住院治疗、需要肝移植和死亡等反面的可能性显著增加。

TAKE-HOME MESSAGE

        This study compared the outcomes of patients with cirrhosis and overt hepatic encephalopathy with those of cirrhotic patients with covert (subclinical) hepatic encephalopathy. Individuals with covert hepatic encephalopathy were followed for hospitalizations and the development of overt hepatic encephalopathy over the next year.

        Patients with cirrhosis who harbored subclinical hepatic encephalopathy were found to have a significantly increased likelihood of developing overt hepatic encephalopathy, being hospitalized, undergoing transplantation, and dying compared with those without.

分享:

评论

我要跟帖
发表
回复 小鸭梨
发表

copyright©医学论坛网 版权所有,未经许可不得复制、转载或镜像 京ICP证120392号 京公网安备11010502031486号

京卫网审[2013]第0193号

互联网药品信息服务资格证书:(京)-经营性-2012-0005

//站内统计 //百度统计 //站长统计
*我要反馈: 姓    名: 邮    箱: